Some cookies are essential to the running of the website, while others (analytics) help us to make improvements. We also incorporate functionality from other websites, such as video, social media feeds and ReachDeck (text-to-speech and translations services) which may set cookies. More on how we use cookies
This website uses text-to-speech software called ReachDeck to read and / or translate its content. To use ReachDeck, you must allow ReachDeck cookies; the ReachDeck icon will then appear at the bottom of your screen.
You can find out more about how ReachDeck uses cookies or change your cookie preferences at any time by going to our cookies page.
Allow ReachDeck cookies Do not use ReachDeck
This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.
Also known as: C1EQ; C1 Esterase Inhibitor
C1 esterase inhibitor deficiency is the most common complement deficiency (antigenic or functional) and is transmitted as an autosomal dominant disorder resulting in hereditary angioneurotic oedema. Acquired C1 inhibitor deficiency may occur with B-cell lymphomas and some autoimmune diseases. Samples collected during an acute attack of angioedema due to C1 inhibitor deficiency are characterised by a low C4. Conversely, a normal C4 level virtually excludes all forms of C1 inhibitor deficiency.
Functional activity: 5ml EDTA
Serum levels: 1ml serum
Price on application
21 days
8 days (must be stored at -80ºC)
6 hours (must be stored at -80ºC)
Samples need to reach the Laboratory within 6 hours of venepuncture.
For further information, email immunology.office@nhs.net